Peripheral reductive capacity is associated with cognitive performance and survival in Alzheimer's disease
2006

Peripheral Reductive Capacity and Alzheimer's Disease

Sample size: 51 publication 10 minutes Evidence: moderate

Author Information

Author(s): Minghetti Luisa, Greco Anita, Puopolo Maria, Combrinck Marc, Warden Donald, Smith A David

Primary Institution: Istituto Superiore di Sanità, Rome, Italy

Hypothesis

Is there an association between peripheral anti-oxidant capacity and cognitive performance in Alzheimer's disease patients?

Conclusion

Peripheral anti-oxidant defences are depleted in Alzheimer's disease patients, and higher serum AOC levels are associated with longer survival.

Supporting Evidence

  • Serum AOC levels were lower in AD patients than in controls.
  • AOC levels were correlated with cognitive test scores.
  • Higher AOC levels predicted longer survival in AD patients.

Takeaway

People with Alzheimer's disease have lower levels of certain anti-oxidants in their blood, which can help predict how long they might live.

Methodology

The study measured total reductive capacity in serum samples from 26 cognitively normal controls and 25 Alzheimer's disease patients.

Limitations

The study may have been underpowered to detect associations between AOC levels and cognitive decline over time.

Participant Demographics

26 cognitively normal controls and 25 Alzheimer's disease patients, with a median age of 71.1 years.

Statistical Information

P-Value

p = 0.0098

Confidence Interval

95% C.I. = 0.12–0.97

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1742-2094-3-4

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication